Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.
Venous complications of pacemaker/ implantable cardioverter defibrillator (ICD) system implantation rarely cause immediate clinical problems. The challenge starts when patients come for system revision or upgrade. Numerous reports of venous complications such as stenosis, occlusions, and superior vena cava syndrome have been published. We reviewed current knowledge of these complications, management, and their impact on upgrade/revision procedures. One study has suggested that intravenous lead infection promotes local vein stenosis. Another found that the presence of a temporary wire before implantation is associated with an increased risk of stenosis. Although data for ICD leads is based only on three studies-it suggests that the rate of venous complications is very similar to that of pacing systems, and probably data from pacing leads can be extrapolated to ICD leads. Despite 40 years of experience with transcutaneous implanted intravenous pacing systems and dozens of studies, we were unable to identify clear risk factors (confirmed by independent studies) that lead to venous stenosis. Neither the hardware (lead size, number and material) nor the access site choice (cephalic cut down, subclavian or axillary puncture) appears to affect rate of venous complications. A few factors were proposed as predictors of severe venous stenosis/occlusion: presence of multiple pacemaker leads (compared to a single lead), use of hormone therapy, personal history of venous thrombosis, the presence of temporary wire before implantation, previous presence of a pacemaker (ICD as an upgrade) and the use of dual-coil leads. Anticoagulant therapy (for other reasons than pacemaker lead) seemed to have protective antithrombotic effect.
Rozmus
Grzegorz
G
Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Strong Memorial Hospital, 601 Elmwood Ave., Box 679, Rochester, NY, 14642, USA. GrzegorzRozmus@URMC.rochester.edu
Daubert
James P
JP
Huang
David T
DT
Rosero
Spencer
S
Hall
Burr
B
Francis
Charles
C
D000368:Aged; D017130:Angioplasty / Q000379:methods; D003131:Combined Modality Therapy; D003251:Constriction, Pathologic / Q000209:etiology / Q000503:physiopathology; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D020878:Device Removal; D004868:Equipment Failure; D005260:Female; D006801:Humans; D018810:Magnetic Resonance Angiography; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D010690:Phlebography / Q000379:methods; D011379:Prognosis; D018570:Risk Assessment; D013479:Superior Vena Cava Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D018608:Ultrasonography, Doppler; D034941:Upper Extremity; D020246:Venous Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality / Q000628:therapy*